These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Sparfloxacin and levofloxacin. Med Lett Drugs Ther; 1997 Apr 25; 39(999):41-3. PubMed ID: 9137295 [No Abstract] [Full Text] [Related]
3. Criteria for use of ofloxacin and lomefloxacin in adult inpatients and outpatients. Spivey IM. Clin Pharm; 1993 Jun 25; 12(6):452-8. PubMed ID: 8403817 [No Abstract] [Full Text] [Related]
5. [The importance of fluoroquinolones in treating pneumonia in the elderly]. Belousov IuB, Efremenkova OV, Sokolov AV, Tishenkova IF. Antibiot Khimioter; 1999 Jun 25; 44(12):23-6. PubMed ID: 10687030 [No Abstract] [Full Text] [Related]
6. New antibiotic approved for community-acquired infections. Nurse Pract; 1998 Jan 25; 23(1):94. PubMed ID: 9470200 [No Abstract] [Full Text] [Related]
7. Drug not considered a first-line agent. Lexchin J. Can Fam Physician; 1998 Nov 25; 44():2376. PubMed ID: 9839049 [No Abstract] [Full Text] [Related]
8. Comparative efficacy of sparfloxacin in comparison with amoxycillin plus ofloxacin in the treatment of community-acquired pneumonia. French Study Group. Portier H, May T, Proust A. J Antimicrob Chemother; 1996 May 25; 37 Suppl A():83-91. PubMed ID: 8737128 [Abstract] [Full Text] [Related]
11. Moxifloxacin: new preparation. A me-too with more cardiac risks. Prescrire Int; 2002 Dec 25; 11(62):168-9. PubMed ID: 12469694 [Abstract] [Full Text] [Related]
14. Levofloxacin and trovafloxacin: the next generation of fluoroquinolones? Ernst ME, Ernst EJ, Klepser ME. Am J Health Syst Pharm; 1997 Nov 15; 54(22):2569-84. PubMed ID: 9397218 [Abstract] [Full Text] [Related]